Replacement therapy should be offered to adults with severe growth hormone deficiency

BMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7080.600 (Published 22 February 1997) Cite this as: BMJ 1997;314:600
  1. Stephen Shaleta
  1. a Department of Endocrinology, Christie Hospital, Manchester M20 4BX

    Editor-In 1996 adult growth hormone deficiency became a licensed indication for growth hormone replacement therapy. Under most circumstances it is not difficult to identify patients likely to have severe growth hormone deficiency. We screen this cohort and assess their need for replacement therapy. Because of current health economic policies we are unable to provide a supply of growth hormone from the hospital and therefore ask the patient's general practitioner to do this. We provide a shared care …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription